Health-tech company Practo is reinforcing its leadership structure as it moves towards its next phase of growth.
The company has made multiple senior-level appointments over the past year, signalling preparations for scaling operations and a potential public listing.
Since February 2025, Practo has onboarded 5 senior leaders across key functions including operations, marketing, artificial intelligence, product, and corporate development.
The appointments include Jagnoor Singh as global chief operating officer, Shoumyan Biswas as global chief marketing and strategy officer, Sonam Chopra as head of corporate development, Cijo George as vice president of AI and Srijesh K as chief product and technology officer, with the latter two joining in February 2026.
In addition to executive appointments, the company has also strengthened its board with the induction of former Union Health Secretary C.K. Mishra as an independent director, bringing decades of policy and governance experience.
The new leadership team brings experience from major consumer and technology firms. Jagnoor Singh, who previously worked with Unacademy, Airtel, OYO and Mondelez, is leading go-to-market initiatives and international expansion.
Shoumyan Biswas, formerly associated with Tata Digital and Flipkart, is responsible for global marketing strategy and consumer engagement.
On the technology front, Cijo George is overseeing AI-led capabilities across search, symptom analysis and clinical feedback systems, while Srijesh K is managing product and technology alignment. Sonam Chopra is leading corporate development initiatives.
Despite these additions, the company continues to retain long-standing leaders. Executives such as Sarang Sharma, Kshitij Bhotika, Pranay GN, Satish Arunachalam and Rowel Coelho remain in key roles, reflecting continuity within the organisation.
Practo has evolved beyond its early positioning as a doctor discovery platform and is now building a broader healthcare ecosystem spanning care navigation, provider software and patient engagement.
The company is increasingly focusing on improving user experience, driving repeat usage, and deepening engagement rather than relying solely on expansion.
Artificial intelligence is emerging as a key component of this shift, particularly in areas such as discovery, triage, and clinical workflows.
Backed by investors including Peak XV Partners, Z47, Tencent Holdings and Sofina, Practo is targeting an annualised gross merchandise value of $1 billion by June 2026. Its US operations are expected to contribute between $250 million and $300 million to this total.
This represents a significant increase from approximately $400 million GMV in the previous financial year, driven by growth in its marketplace business and international operations. The company expects this momentum to support a potential IPO by the end of the year.
Read More: NPCIL IPO Likely in 2026 as Budget Cuts Equity Support!
With a strengthened leadership team, evolving business model and ambitious growth targets, Practo is positioning itself for its next phase, with a potential public listing on the horizon.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 8, 2026, 9:23 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
